Catalyst
Slingshot members are tracking this event:
Novo Nordisk expects to file semaglutide for regulatory review in the US and EU in the fourth quarter of 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NVO | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 05, 2016
Occurred Source:
http://www.novonordisk.com/media/news-details.2061793.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Semaglutide, Regulatory Review, Q4 2016
